Aspen Aerogels (ASPN)
(Delayed Data from NYSE)
$16.10 USD
+0.39 (2.48%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $16.08 -0.02 (-0.12%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth F Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ASPN 16.10 +0.39(2.48%)
Will ASPN be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for ASPN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ASPN
Aspen Aerogels (ASPN) Reports Q4 Loss, Tops Revenue Estimates
Is a Surprise Coming for Aspen Aerogels (ASPN) This Earnings Season?
ASPN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Owens Corning (OC) Earnings Expected to Grow: Should You Buy?
Aspen Aerogels (ASPN) Expected to Beat Earnings Estimates: Should You Buy?
Aspen (ASPN) Provides Preliminary Revenue Results & Guidance
Other News for ASPN
Aspen Aerogels to Participate in May Investor Conferences
Analysts Offer Insights on Industrial Goods Companies: Axon Enterprise (AXON) and Aspen Aerogels (ASPN)
Analysts Offer Insights on Industrial Goods Companies: Aspen Aerogels (ASPN), Canadian National Railway (CNI) and Ritchie Bros (RBA)
Aspen Aerogels management to meet with Roth MKM
Jim Cramer Is 'Willing To Let This Pharma Stock Catch Fire,' Advises Not To Sell McKesson